U.S. Energy Services Stock News

NasdaqCM:CZFS
NasdaqCM:CZFSBanks

Citizens Financial Services (CZFS) Net Interest Margin Strengthens And Challenges Slow Growth Narrative

Citizens Financial Services (CZFS) just closed out FY 2025 with fourth quarter revenue of US$29.1 million and basic EPS of US$2.19, supported by quarterly net income of US$10.5 million. Over the past year, revenue has moved from US$26.5 million in Q4 2024 to US$29.1 million in Q4 2025, while basic EPS has shifted from US$1.66 to US$2.19. This sets up a picture of higher earnings power for the period. With trailing net profit margins at 33.3% and earnings growth of 31.5% over the last 12...
NasdaqGS:NFE
NasdaqGS:NFEOil and Gas

New Fortress Energy (NFE) Is Down 10.9% After Activist Stake And Options Surge - What's Changed

In early March 2026, investor Peter Levinson disclosed a 0.3% stake in New Fortress Energy via a Schedule 13D filing, while options trading ahead of earnings surged to over twice typical volumes with call contracts far outnumbering puts. This combination of an active shareholder presence, heightened options positioning, and existing financial strains has intensified scrutiny of New Fortress Energy’s operations, capital structure, and potential corporate actions. We’ll now examine how...
NasdaqGS:RAIL
NasdaqGS:RAILMachinery

FreightCar America (RAIL) Q4 Loss Tests Bullish Margin Narrative Despite TTM Profitability

FreightCar America (RAIL) closed FY 2025 with Q4 revenue of US$125.6 million and a basic EPS loss of US$0.50, alongside trailing twelve month EPS of US$1.16 on revenue of US$501.0 million. Over the past six reported quarters, quarterly revenue has ranged from US$96.3 million to US$160.5 million, while basic EPS has swung between a profit of US$1.54 and a loss of US$3.57. This sets up a story of improving profitability on a full year view but mixed quarterly execution. That level of earnings...
NYSE:NL
NYSE:NLCommercial Services

NL Industries (NL) Earnings Swing To Loss Challenges Bullish Narratives On Profitability

NL Industries (NL) closed out FY 2025 with Q4 revenue of US$37.7 million and a basic EPS loss of US$0.63, alongside net income excluding extra items of a US$31.0 million loss that puts margins firmly under pressure. The company has seen quarterly revenue move from US$38.4 million in Q4 2024 to US$37.7 million in Q4 2025, while basic EPS shifted from US$0.34 to a loss of US$0.63. That swing matters if you are focused on the trajectory of earnings power. With trailing 12 month net income...
NYSE:AMT
NYSE:AMTSpecialized REITs

American Tower Edge Pilot Highlights AI Opportunity And Valuation Upside Potential

Dispersive Holdings completed a successful pilot with American Tower's Edge Data Center. The pilot focused on AI and other high performance workloads at the edge. Results included measurable gains in throughput, security, and resiliency, including failover performance. For investors watching NYSE:AMT, this update sits at the intersection of towers, data centers, and edge computing. American Tower is widely known for its wireless tower portfolio, and partnerships like this illustrate how its...
NYSE:MTN
NYSE:MTNHospitality

Vail Resorts (MTN) Q2 Net Margin Compression Tests Bullish Earnings Narrative

Vail Resorts (MTN) has just posted its Q2 2026 numbers, reporting revenue of US$1,083.9 million and basic EPS of US$5.87, alongside trailing twelve month EPS of US$6.38 on revenue of US$2.9 billion. The company’s quarterly revenue moved from US$1,137.2 million and EPS of US$6.54 in Q2 2025 to US$1,083.9 million and EPS of US$5.87 in Q2 2026. The latest trailing figures are in focus for investors considering how earnings power holds up across seasons. With net profit margins easing over the...
NYSE:AMPY
NYSE:AMPYOil and Gas

Amplify Energy (AMPY) One Off Gain Lifts FY 2025 EPS And Tests Earnings Narratives

Amplify Energy FY 2025 Earnings Snapshot Amplify Energy (AMPY) closed out FY 2025 with Q4 revenue of about US$56.6 million and basic EPS of US$1.53, while trailing 12 month EPS sat at US$1.03 on net income of US$41.6 million and a net margin of 15.8% versus 4.2% the prior year, supported by a US$54.7 million one off gain. Over the last few quarters, revenue has moved from US$69.0 million in Q4 2024 to US$72.1 million in Q1 2025, US$68.4 million in Q2, US$66.4 million in Q3 and US$56.6 million...
NasdaqCM:RDNW
NasdaqCM:RDNWSpecialty Retail

RideNow Group (RDNW) Trailing Loss Halves To US$52.4m Reinforcing Earnings Turnaround Narrative

RideNow Group (NasdaqCM:RDNW) has released its FY 2025 numbers, reporting fourth quarter revenue of US$256.9 million and a basic EPS loss of US$0.17. Trailing 12 month revenue was about US$1.1 billion and EPS for the period was a loss of US$1.38. Over the past few quarters, revenue has ranged from US$244.7 million to US$299.9 million per quarter, while quarterly EPS losses have been between US$0.11 and US$0.85. This gives investors a clear view of a business that is generating meaningful...
NasdaqGS:FULT
NasdaqGS:FULTBanks

Fulton Financial HR Shift Puts Focus On Execution And Culture

Fulton Financial (NasdaqGS:FULT) has announced the retirement of Chief Human Resources Officer Bernadette Taylor. Karen Grafje, an internal leader with extensive industry experience, has been promoted to Chief Human Resources Officer. The transition places Grafje in a key role overseeing talent, culture, and workforce initiatives across the company. For investors tracking Fulton Financial at a share price of $20.01, this leadership change follows a mixed stretch of recent stock performance...
NasdaqCM:PRTH
NasdaqCM:PRTHDiversified Financial

Priority Technology Holdings (PRTH) Profit Swing Reinforces Bullish Margin Narratives

Latest FY 2025 earnings snapshot Priority Technology Holdings (PRTH) has wrapped up FY 2025 with fourth quarter revenue of US$247.1 million and EPS of US$0.11, while trailing twelve month EPS sat at US$0.70 on revenue of US$953.0 million. Over recent periods the company has seen revenue move from US$227.1 million in Q4 2024 to US$247.1 million in Q4 2025, with quarterly EPS shifting from a loss of US$0.05 in Q4 2024 to a profit of US$0.11 in Q4 2025 and TTM EPS climbing from a loss of US$0.31...
NYSE:NIO
NYSE:NIOAuto

NIO (NIO) Posts Rare Q4 Profit Challenging Persistent Loss-Making Narrative

NIO (NIO) has closed out FY 2025 with Q4 revenue of C¥34.7b and basic EPS of C¥0.05, alongside trailing twelve month revenue of C¥87.5b and a trailing basic EPS loss of C¥6.85. This puts a spotlight on how quickly the earnings line is moving relative to the top line. The company has seen quarterly revenue move from C¥19.7b and a basic EPS loss of C¥3.45 in Q4 2024 to C¥34.7b and basic EPS of C¥0.05 in Q4 2025. Over the same period, trailing twelve month revenue shifted from C¥65.7b with a...
NYSE:ADCT
NYSE:ADCTBiotechs

ADC Therapeutics (ADCT) Loss Narrowing To US$0.04 EPS Challenges Bearish Profitability Narrative

ADC Therapeutics (ADCT) closed out FY 2025 with Q4 revenue of US$23.1 million and a basic EPS loss of US$0.04, alongside net income excluding extra items of a US$6.4 million loss. The company has seen quarterly revenue move from US$16.9 million in Q4 2024 to US$23.1 million in Q4 2025, while basic EPS losses shifted from US$0.29 to US$0.04 over the same period. This sets the stage for investors to focus on how these headline figures translate into the quality and direction of margins. See our...
NYSE:GBCI
NYSE:GBCIBanks

Did Softer Margins And EPS Pressure Just Shift Glacier Bancorp's (GBCI) Investment Narrative?

In recent months, Glacier Bancorp reported softer quarterly results, with net interest income growth trailing the wider banking industry and earnings per share falling even as revenue increased. This divergence between rising revenue and declining per-share earnings has raised questions about the bank’s efficiency, cost structure, and overall profitability quality. With concerns mounting over weaker quarterly performance and profitability trends, we’ll now examine how this development...
NYSE:NPK
NYSE:NPKAerospace & Defense

Does National Presto (NPK) Holding Its Dividend Signal Enduring Defense Strength Or Mask Tariff Strains?

National Presto Industries, Inc. has affirmed an annual cash dividend of US$1.00 per share, with an ex-dividend and record date of March 9, 2026, and payment scheduled for March 20, 2026. The dividend decision comes after the company reported very strong 2025 net sales growth driven by fulfilling a sizable Defense segment backlog, while its Housewares/Small Appliance business contended with tariff-related pressures on demand and costs. Next, we’ll examine how the Defense segment’s...
NasdaqGS:VECO
NasdaqGS:VECOSemiconductor

Does Veeco (VECO) Becoming InP Laser “Tool of Record” Recast Its AI Datacom Narrative?

In early March 2026, Veeco Instruments Inc. reported that a global leader in optical communications and laser manufacturing placed orders for multiple Lumina Metal Organic Chemical Vapor Deposition systems and Spector Ion Beam Sputtering Optical Coating systems to produce indium phosphide lasers for datacom applications. This order effectively designates Lumina as the customer’s production tool of record for InP epitaxy, underlining Veeco’s role in enabling optical transceivers that connect...
NYSE:RSI
NYSE:RSIHospitality

Has Rush Street Interactive (RSI) Run Too Far After Its 108% One-Year Rally?

If you are wondering whether Rush Street Interactive's share price still makes sense after a strong run, looking closely at what you are paying for today versus the underlying fundamentals is a useful place to start. The stock last closed at US$20.73, with returns of 3.9% over the past 7 days, 17.3% over the past 30 days, 7.4% year to date, 108.1% over the past year and a very large gain over 3 years. Recent coverage around Rush Street Interactive has focused on its position in online gaming...
NasdaqCM:SBET
NasdaqCM:SBETHospitality

SharpLink Gaming (SBET) Q3 Profit Swing Challenges Longstanding Loss‑Focused Narratives

Sharplink (NasdaqCM:SBET) just posted its FY 2025 third quarter numbers with total revenue of about US$10.8 million and basic EPS of US$0.70, a sharp contrast to the trailing twelve month EPS of a US$0.02 loss on revenue of roughly US$13.1 million. Over recent quarters the company has reported revenue of roughly US$0.7 million, then US$0.8 million, and most recently US$10.8 million. Over the same period, quarterly EPS has moved from losses of around US$3.08 per share to US$4.27 per share to a...
NYSE:LW
NYSE:LWFood

Starboard Pressure On Lamb Weston Cost Cuts And Asset Sales Meets Valuation Gap

Starboard Value LP has publicly urged Lamb Weston Holdings to increase its cost savings program, with a heavier focus on SG&A expenses. The activist investor is also pressing the company to review its international footprint, including the possibility of divesting select APAC assets. This push could influence Lamb Weston Holdings' capital allocation priorities and operating approach in the near term. For investors watching NYSE:LW, this development follows a challenging share price period,...
NasdaqGS:COKE
NasdaqGS:COKEBeverage

Assessing Coca-Cola Consolidated (COKE) Valuation After Independence Deal And Strong Fundamental Performance

Coca-Cola Consolidated (COKE) has drawn fresh attention after fully buying out Coca-Cola's equity interest for US$2.4b last November. This move leaves the bottler operating as an independent company. See our latest analysis for Coca-Cola Consolidated. The independence deal is landing against a strong run in Coca-Cola Consolidated's shares, with the stock at US$206.91 and a 30-day share price return of 31.17% alongside a 1-year total shareholder return of 69.85%. This suggests momentum has...
NasdaqGM:VCEL
NasdaqGM:VCELBiotechs

Is Vericel (VCEL) Pricing Justified After A 30% One-Year Share Price Decline

If you are trying to work out whether Vericel is attractively priced today, it helps to step back and look at both its recent share performance and what the numbers say about value. Vericel shares last closed at US$34.12, with returns of 3.5% decline over 7 days, 5.7% decline over 30 days, a 4.2% decline year to date and a 30.2% decline over the last year, while the 3 year return is 15.3% and the 5 year return is 28% decline. Recent price moves sit against a backdrop of ongoing interest in...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

The Bull Case For Krystal Biotech (KRYS) Could Change Following Q4 Beat And CEO Stock Sales

In recent weeks, Krystal Biotech reported financial results for the fourth quarter of 2025 that exceeded analyst expectations for both earnings and revenue, while President and CEO Krishnan Krish S executed US$6.58 million of pre-planned stock sales under a Rule 10b5-1 trading plan. This combination of financial outperformance and insider selling offers fresh insight into how management is monetizing equity while the core business appears to be executing ahead of external forecasts. Next,...
NasdaqGS:IMCR
NasdaqGS:IMCRBiotechs

Will Immunocore's (IMCR) 2025 Revenue Growth and Narrower Loss Reshape Its Investment Narrative?

Immunocore Holdings plc recently reported fourth-quarter 2025 revenue of US$104.48 million and a quarterly net loss of US$30.06 million, alongside full-year 2025 revenue of US$400.02 million and a full-year net loss of US$35.51 million. The company paired this earnings update with a packed schedule of March 2026 healthcare conference appearances in Boston and Miami, signaling active engagement with investors and the broader biotech community. We’ll now examine how the full-year revenue...
NYSE:PINE
NYSE:PINEREITs

Should Alpine’s New High‑Coupon Mortgage Loan Strategy Shape How Investors View PINE’s Risk Profile?

Alpine Income Property Trust, Inc. recently originated a US$32.0 million first mortgage loan, funding US$8.6 million at close, to back the development of an 11‑acre, 101,000‑square‑foot retail center with investment grade tenants and three outparcels in the Covington Town Center master plan near Atlanta. The high‑coupon, 24‑month loan tied to a Target‑anchored project adjacent to an existing Publix highlights Alpine’s growing use of higher‑yield structured financing alongside its net lease...
NasdaqCM:RLMD
NasdaqCM:RLMDPharmaceuticals

A Look At Relmada Therapeutics (RLMD) Valuation After NDV‑01 Phase 2 Bladder Cancer Data

Phase 2 NDV-01 data and what it could mean for Relmada Therapeutics (RLMD) Relmada Therapeutics (RLMD) has drawn fresh attention after reporting 12 month interim Phase 2 data for NDV-01 in high risk non muscle invasive bladder cancer, showing strong complete response rates and a favorable safety profile. See our latest analysis for Relmada Therapeutics. The NDV-01 update and recent Leerink healthcare conference appearance came alongside a sharp shift in sentiment, with Relmada Therapeutics’ 1...